Hereditary angioedema: Family history and clinical manifestations in 58 patients;Angioedema hereditario: Historia familiar y manifestaciones clinicas en 58 pacientes

Medicina

Volumn 69, Issue 6, 2009, Pages 601-606

  Fernandez Romero, Diego S ^a   Dl Marco, Pamela ^a   Malbran, Alejandro ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Angioedema attacks; C1 inhibitor; Hereditary angioedema

Indexed keywords

AMINOCAPROIC ACID; COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL; FRESH FROZEN PLASMA; TRANEXAMIC ACID;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASPHYXIA; DEATH; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUTATION; STRESS;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ARGENTINA; ASPHYXIA; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HEREDITARY ANGIOEDEMA TYPES I AND II; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 75149179061     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Frank MM, Gelfand JA, Atkinson JP. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976; 84: 589-93.
2. Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982; 284: 2-9.
3. Agostoni A, Cicardi M. Hereditary and acquired C-1 inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992; 71: 206-15.
4. Bowen T, Cicardi M, Fakas H, et al. Canadian 2003 International Consensus Algorithm for the diagnosis, therapy and management of hereditary angioedema. J Allergy Clin Immunol 2004; 114: 629-37.
5. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1-esterase. Am J Med 1963; 31: 37-44.
6. Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science 1965; 148: 957-8.
7. Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol 1988; 6: 595-628.
8. Zuraw BL. Hereditary angioedema. N Engl J Med 2008; 359: 1027-36.
9. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angioedema. Lancet 1998; 351: 1693-7.
10. Nussberger J, Cugno M, Cicardi M, Agostoni A. Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 1999; 104: 1321-2.
11. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347: 621-2.
12. Han ED, MacFarlane RC, Mulligan AN, Scafidi J, Davis AE III. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 2002; 109: 1057-63.
13. Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006; 101: 1-9.
14. Bork K, Siedlecki K, Bosch S, Schopf RE. Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000; 75: 349-54.
15. Bork K, Hardt J, Schicketanz K, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003; 163: 1229-35.
16. Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 2006; 26: 653-68.
17. Zuraw BL, MD. Novel Therapies for Hereditary Angioedema. Immunol Allergy Clin N Am 2006; 26: 691-708.
18. Bork K, Frank J, Grundt B, Schiattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (lcatibant) J Allergi Clin Immunol 2007; 119: 1497-503.
19. Frank MM. Hereditary angioedema. Curr opin pediatr 2005; 17: 686-9.
20. Pappalardo E, Cicardi M, Duponchel C, Carugati A Choquet S, Agostoni A, et al. Frequent de novo mutation and exon deletion in the C1 inhibitor gene of patients with angioedema. J Allergy Clin Immunol 2000; 106: 1147-54.
21. Huang SW. Result of an on line survey of patients with hereditary Angiedema. Allergy Asthma Proc 2004; 114: 626-8.
22. Nielsen EW, Gran JT, Straume B, Mellbye OJ, Johansens HT, Mollnes TE. Hereditary angioedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses. J lnt Med 1996; 239: 119-30.
23. Kunschak M, Engl W, Maritsch F, et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998; 38: 540-9.
24. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001; 161: 714-8.
25. Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Transfus Apher Sci 2003; 29: 221-7.
26. Farkas H, Jakab L, Temesszentandrási G, et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 2007; 120: 941-7.
27. Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 2005; 45:1774-84.
28. Bork K, Ressel N. Sudden upper airway obstruction in patients with hereditary angioedema. Tranfus Apheresis Sci 2003; 29: 235-8.